169 related articles for article (PubMed ID: 31460497)
1. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
[TBL] [Abstract][Full Text] [Related]
2. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
[TBL] [Abstract][Full Text] [Related]
3. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
Murugappan MN; Seifert RD; Farley JF
J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
Allen A; Hung A
J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
[TBL] [Abstract][Full Text] [Related]
5. Reprint of: Examining Medicare Part D Medication Therapy Management program in the context of mental health.
Murugappan MN; Seifert RD; Farley JF
J Am Pharm Assoc (2003); 2020; 60(5S):S54-S63. PubMed ID: 32977930
[TBL] [Abstract][Full Text] [Related]
6. Medicare Medication Therapy Management: beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013-2016).
Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
J Am Pharm Assoc (2003); 2024 May; ():102140. PubMed ID: 38825153
[TBL] [Abstract][Full Text] [Related]
7. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
[TBL] [Abstract][Full Text] [Related]
8. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
10. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
[TBL] [Abstract][Full Text] [Related]
11. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
[TBL] [Abstract][Full Text] [Related]
13. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
[TBL] [Abstract][Full Text] [Related]
16. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries.
Moczygemba LR; Barner JC; Gabrillo ER; Godley PJ
Am J Health Syst Pharm; 2008 Sep; 65(17):1655-60. PubMed ID: 18714113
[TBL] [Abstract][Full Text] [Related]
17. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
19. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
